SYSTEMATIC SYMPTOM ASSESSMENT IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS

NCT04929353 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
280
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Of Perugia